VB18214

N/A

Report date: 2025/04/29 16:10:09
NME

Base Information

Drug NameVB18214
Drug Alias NameVB18214VB-18214
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 2 inhibitors
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Yangli Medical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Yangli Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A